The protocol presents the imaging and computational workflow to extract and validate imaging-based chromatin and epigenetic age (ImAge).
Method Article
* These authors contributed equally
The protocol presents the imaging and computational workflow to extract and validate imaging-based chromatin and epigenetic age (ImAge).
To advance personalized healthcare and assess potential rejuvenation strategies, biomarkers reflecting biological age are crucial. We have introduced imaging-based chromatin and epigenetic age (ImAge), an imaging-based biomarker derived from the spatial organization of chromatin and epigenetic marks within single nuclei, capturing intrinsic age-related changes. ImAge effectively captures and quantifies the effects of interventions modulating biological age, showing sensitivity through significant decreases following rejuvenation strategies (such as caloric restriction and partial reprogramming through transient Oct4, Sox2, Klf4, and Myc (OSKM) expression) and increases after treatments like chemotherapy. Furthermore, lower ImAge correlated with higher locomotor activity, suggesting it captures functional improvements alongside biological age reversal, offering a promising single-cell tool to evaluate longevity interventions. As ImAge is an integrative method requiring good-quality imaging and meticulous computational analysis, we aim to provide thorough guidance to extract and validate it. This comprehensive protocol will detail the workflow for both wet laboratory procedures (sample preparation and imaging) and the proper utilization of our open-sourced computational pipeline (environment setup and processing of the imaging data) to extract and validate ImAge.
The increasing average lifespan and an aging global population underscore the critical need for effective biomarkers of functional or biological age1,2,3. These biomarkers are essential for accurately predicting disease risk and lifespan, which can significantly enhance geriatric care and reduce associated costs. While DNA methylation (DNAm) clocks have made notable advancements in quantifying biological aging4,5,6, they often rely on linear regression and necessitate large cohorts, potentially overlooking nuanced, context-dependent biological components specific to individuals7,8. Furthermore, these sequencing-based techniques require cell lysis, complex sample preparation, and expensive reagents for each cell, making them more costly and challenging for high-throughput, large-scale, or longitudinal studies where sample destruction is a disadvantage9.
To overcome these limitations, we developed imaging-based chromatin and epigenetic age (ImAge), a novel technique designed to quantify aging and rejuvenation at single-cell resolution. This technique was applied and validated in mouse peripheral blood and various solid organs as described by Alvarez-Kuglen et al.1. This publication describes the optimized protocols in detail such that they can be adapted and adopted by other researchers for various applications.
This approach fundamentally differs from traditional DNAm clocks by capturing intrinsic age-related trajectories based on the spatial organization of chromatin and epigenetic marks within single nuclei1. Imaging-based methods offer distinct advantages: it is inherently non-destructive, meaning cells are not destroyed during processing, unlike sequencing-based methods. This non-destructive nature crucially allows for the preservation of the spatial structure of chromatin and epigenetic marks at the single-cell level, maintaining the spatial context of cells within tissues-a perspective often lost in conventional sequencing workflows. Furthermore, imaging techniques are generally more cost-effective for large-scale or longitudinal studies, as they do not require expensive reagents or complex library preparation per cell, making them suitable for repeated observations over time10,11.
A key advantage of ImAge is its ability to reveal age-related trajectories as intrinsic principal features of the data itself, without requiring regression on chronological age. ImAge has demonstrated a strong correlation with chronological age in mouse peripheral blood mononuclear cells and various solid organs1. Crucially, ImAge effectively captures expected perturbations to biological age, showing an increase following chemotherapy treatment and a decrease with caloric restriction and partial reprogramming by transient OSKM expression in liver and skeletal muscle. Furthermore, ImAge readouts have been observed to inversely correlate with locomotor activity in chronologically identical mice, indicating their utility in measuring aspects of biological and functional age.
Implementing the ImAge methodology necessitates expertise in both wet-lab experimental procedures12 and computational analyses1 (Figure 1); therefore, this paper provides comprehensive, step-by-step protocols for both aspects. This optimized protocol aims to facilitate the widespread adoption of ImAge, enabling researchers to investigate age-associated changes in chromatin and epigenetic organization at single-cell resolution across various cell types and tissues. In this protocol, H3K27ac and H3K27me3, two markers that provide sufficient contrast and resolution for determining ImAge, were selected as representative marks. Researchers can replicate this protocol to quantify biological aging, assess the impact of longevity interventions, and explore the inherent heterogeneity within aging and rejuvenation processes at the individual organism level.
Access restricted. Please log in or start a trial to view this content.
All animal experiments are conducted according to guidelines and protocols approved by the Institutional Animal Care and Use Committee (IACUC) of The Scripps Research Institute (Protocol 09-0004-6). Data presented within this manuscript were obtained using male i4F mice, ranging in age from 2 to 14 months of age. Organs of interest (liver and skeletal muscle) were harvested from 13.8-month-old i4F and littermate control mice treated for 1 week with a low dose of doxycycline (0.2 mg/ml)14. Nuclei were isolated from samples of young (3.2 months), aged (13.8 months), and aged treated with doxycycline to overexpress OSKM factors (aged-OSKM).
1. Imaging of samples
2. Computational analysis of imaging data
Access restricted. Please log in or start a trial to view this content.
Representative images should be well populated to obtain single cells, yet individual nuclei should not be touching each other, since it will degrade the quality of the cell nuclei segmentation. Figure 3 shows the representative imaging to obtain robust computational analysis results.
Results outlined in this methods manuscript are adapted from the ImAge manuscript by Alvarez-Kuglen et al.1. ImAge successfully detected the reversal of aging...
Access restricted. Please log in or start a trial to view this content.
Sample Preparation
For sample preparation, promptly harvest tissues of interest and immediately flash-freeze them in liquid nitrogen. When grinding tissue with a mortar and pestle, a silicone cover for the mortar can be used to prevent sample loss. Add more liquid nitrogen if the tissue is difficult to pulverize. For more fragile tissues, samples can also be processed fresh (rather than frozen) to reduce mechanical disruption or tissue damage. Nuclei isolation protocols may need optimization depend...
Access restricted. Please log in or start a trial to view this content.
The authors declare no conflicts of interest.
We thank all current and former Terskikh lab members for their help with establishing the protocols and computational framework. This work was supported by National Institutes of Health grants R21 AG068913, R21 AG075483, R21 AG083782, and the Future Health Research and Innovation Fund of the WA Department of Health, BU/PG: 01760/47004300 to A.V.T.
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Bovine Serum Albumin | Sigma-Aldrich | A9647 | |
| Donkey Anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa 488 | Invitrogen | A-21202 | |
| Donkey Anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa 555 | Invitrogen | A-31572 | |
| Glycine | Bio-Rad | 161-0718 | |
| Histone H3K27ac antibody (mAb) | Active Motif | 39685 | |
| Histone H3K27me3 antibody (pAb) | Active Motif | 39155 | |
| Hoechst 33342 | Invitrogen | H3570 | |
| Nuclei Isolation Kit: Nuclei EZ Prep | Sigma-Aldrich | NUC101 | |
| Operetta CLS High Content Imager | Revvity | https://www.revvity.com/au-en/product/operetta-cls-system-hh16000020 | |
| Paraformaldehyde 16% Aqueous Solution EM Grade | Electron Microscopy Sciences | 15710-S | |
| PBS | Thermo Fisher | AM9624 | |
| PhenoPlate 384-well Microplate | Revvity | 6057302 | |
| Triton-X | Sigma | T8787 | |
| Trypan Blue Solution, 0.4% | Gibco | 15250061 |
Access restricted. Please log in or start a trial to view this content.
Request permission to reuse the text or figures of this JoVE article
Request Permission